The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of ifosfamide and mesna in metastatic castration-resistant prostate cancer after taxane-based chemotherapy and novel hormonal therapy failure.
 
Chang Gon Kim
Honoraria - Boryung
Consulting or Advisory Role - Amgen; Johnson & Johnson/Janssen; Novartis; Ono Pharmaceutical; Pfizer
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Dong-A ST; Hanmi; Merck; MSD Oncology; Novartis; Takeda
Research Funding - Ipsen
 
Yeo Gyeong Ko
No Relationships to Disclose
 
Jongjin Yoon
No Relationships to Disclose
 
Chung Lee
No Relationships to Disclose
 
Seung-Hoon Beom
No Relationships to Disclose
 
Young Deuk Choi
No Relationships to Disclose
 
Woong Kyu Han
No Relationships to Disclose
 
Won Sik Ham
No Relationships to Disclose
 
Hyunho Han
No Relationships to Disclose
 
Jongsoo Lee
No Relationships to Disclose
 
Ji Eun Heo
No Relationships to Disclose
 
Daeseong Kim
No Relationships to Disclose
 
Eunsil Baek
No Relationships to Disclose
 
Sang Woo Kim
No Relationships to Disclose
 
Minsun Jung
No Relationships to Disclose
 
Sang Joon Shin
No Relationships to Disclose